Nogata Y, Sakamoto K, Shiratsuchi H, Ishii T, Yano M, Ohta H (2006). “Flavonoid composition of fruit tissues of citrus species”. Biosci Biotechnol Biochem70: 178-192. doi:10.1271/bbb.70.178. PMID16428836.
Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T, Kumai K, Kameyama K, Fujii M, Yano M, Sato T, Ito A, Kitajima M (2004). “Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation”. Aliment Pharmacol Ther1: 95-101. doi:10.1111/j.1365-2036.2004.02082.x. PMID15298613.
Tanaka S, Sato T, Akimoto N, Yano M, Ito A (2004). “Prevention of UVB-induced photoinflammation and photoaging by a polymethoxy flavonoid, nobiletin, in human keratinocytes in vivo and in vitro”. Biochem Pharmacol68: 433-439. doi:10.1016/j.bcp.2004.04.006. PMID15242810.
Akachi T, Shiina Y, Ohishi Y, Kawaguchi T, Kawagishi H, Morita T, Mori M, Sugiyama K (2010). “Hepatoprotective effects of flavonoids from shekwasha (Citrus depressa) against D-galactosamine-induced liver injury in rats”. J Nutr Sci Vitaminol56 (1): 60-67. doi:10.3177/jnsv.56.60. PMID20354348.
Matsuzaki K, Miyazaki K, Sakai S, Yawo H, Nakata N, Moriguchi S, Fukunaga K, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y (2008). “Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus”. Eur J Pharmacol578 (2-3): 194-200. doi:10.1016/j.ejphar.2007.09.028. PMID17976577.
nih.gov
pubmed.ncbi.nlm.nih.gov
Nogata Y, Sakamoto K, Shiratsuchi H, Ishii T, Yano M, Ohta H (2006). “Flavonoid composition of fruit tissues of citrus species”. Biosci Biotechnol Biochem70: 178-192. doi:10.1271/bbb.70.178. PMID16428836.
Minagawa A, Otani Y, Kubota T, Wada N, Furukawa T, Kumai K, Kameyama K, Okada Y, Fujii M, Yano M, Sato T, Ito A, Kitajima M (2001). “The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice”. Jpn J Cancer Res92 (12): 1322-1328. PMID11749698.
Sato T, Koike L, Miyata Y, Hirata M, Mimaki Y, Sashida Y, Yano M, Ito A. (2002). “Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells”. Cancer Res62 (4): 1025-1029. PMID11861377.
Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T, Kumai K, Kameyama K, Fujii M, Yano M, Sato T, Ito A, Kitajima M (2004). “Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation”. Aliment Pharmacol Ther1: 95-101. doi:10.1111/j.1365-2036.2004.02082.x. PMID15298613.
Tanaka S, Sato T, Akimoto N, Yano M, Ito A (2004). “Prevention of UVB-induced photoinflammation and photoaging by a polymethoxy flavonoid, nobiletin, in human keratinocytes in vivo and in vitro”. Biochem Pharmacol68: 433-439. doi:10.1016/j.bcp.2004.04.006. PMID15242810.
Akachi T, Shiina Y, Ohishi Y, Kawaguchi T, Kawagishi H, Morita T, Mori M, Sugiyama K (2010). “Hepatoprotective effects of flavonoids from shekwasha (Citrus depressa) against D-galactosamine-induced liver injury in rats”. J Nutr Sci Vitaminol56 (1): 60-67. doi:10.3177/jnsv.56.60. PMID20354348.
Matsuzaki K, Miyazaki K, Sakai S, Yawo H, Nakata N, Moriguchi S, Fukunaga K, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y (2008). “Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus”. Eur J Pharmacol578 (2-3): 194-200. doi:10.1016/j.ejphar.2007.09.028. PMID17976577.
